ADIPOQ and Insulin resistance: The exact pathogenic mechanisms of hypoadectinemia in patients taking VPA remain unclear, but it is most likely multifactorial and may include direct interaction between VPA and adiponectin expression as well as changes in insulin resistance, weight gain, and fat tissue distribution [81,86].